507
© The Editor(s) (if applicable) and The Author(s), under exclusive license
to Springer Nature Switzerland AG 2021
M. S. H. Akash et al. (eds.), Endocrine Disrupting Chemicals-induced
Metabolic Disorders and Treatment Strategies, Emerging Contaminants
and Associated Treatment Technologies,
https://doi.org/10.1007/978-3-030-45923-9
A
Acromegaly, 28
Active pharmaceutical ingredient (API), 421
Acute adrenal insufficiency, 26
Acute dysfunction, 26
Acute hypoparathyroidism, 26
Adaptogenic herb, 473
Addison’s disease, 27
Adipocyte differentiation, 312–314
Adipocytes, 255, 257, 258
Adipogenesis, 282, 284, 287, 288
Adipokine secretion, 314
Adiponectin, 257
Adrenal cortex, 15
Adrenal cortex hormone (ACTH), 27
Adrenal cortex hyperplasia, 77
Adrenal gland, 13
adrenal cortex, 15
adrenal medulla, 14
arteries and aorta, 14
catecholamines, 14
visceral organs, 15
Adrenal insufficiency, 27
Adrenal medulla, 14
Adrenocorticotropic hormone (ACTH),
9, 15, 79
androgens, 9
stress, 9
Aflatoxicosis, 384
Aflatoxins (AFs)
AFB and AFG, 382
in animal products, 382
biotransformation, 383
in liver, 383
phase-I metabolism, 383–384
phase-II metabolism, 383, 384
carcinogenicity, 382
contamination, 382
dietary interventions, 386
food-borne toxin, 382
furanocoumarins family, 382
mechanism of toxicity
inflammatory responses, 385
lipid metabolism, 385
oxidative stress, 384
mycotoxins, 382
outbreak, 382, 383
pre-harvest approaches, 385
strategies to control, 385–386
Agricultural land, 266
Agriculture policies, 292
Agrochemicals
fertilizers, 266
pesticides, 266
Alpha linolenic acid (ALA), 398
Amaranth oil, 495
Amid chemical treatments, 195
Ammonia, 345
Anderson’s disease, 50
Animal starch, 49
Anterior pituitary gland
ACTH, 9
FSH, 9
growth hormones, 7
prolactin, 8
TSH, 8
Index
© The Editor(s) (if applicable) and The Author(s), under exclusive license
to Springer Nature Switzerland AG 2021
M. S. H. Akash et al. (eds.), Endocrine Disrupting Chemicals-induced
Metabolic Disorders and Treatment Strategies, Emerging Contaminants
and Associated Treatment Technologies,
https://doi.org/10.1007/978-3-030-45923-9
A
Acromegaly, 28
Active pharmaceutical ingredient (API), 421
Acute adrenal insufficiency, 26
Acute dysfunction, 26
Acute hypoparathyroidism, 26
Adaptogenic herb, 473
Addison’s disease, 27
Adipocyte differentiation, 312–314
Adipocytes, 255, 257, 258
Adipogenesis, 282, 284, 287, 288
Adipokine secretion, 314
Adiponectin, 257
Adrenal cortex, 15
Adrenal cortex hormone (ACTH), 27
Adrenal cortex hyperplasia, 77
Adrenal gland, 13
adrenal cortex, 15
adrenal medulla, 14
arteries and aorta, 14
catecholamines, 14
visceral organs, 15
Adrenal insufficiency, 27
Adrenal medulla, 14
Adrenocorticotropic hormone (ACTH),
9, 15, 79
androgens, 9
stress, 9
Aflatoxicosis, 384
Aflatoxins (AFs)
AFB and AFG, 382
in animal products, 382
biotransformation, 383
in liver, 383
phase-I metabolism, 383–384
phase-II metabolism, 383, 384
carcinogenicity, 382
contamination, 382
dietary interventions, 386
food-borne toxin, 382
furanocoumarins family, 382
mechanism of toxicity
inflammatory responses, 385
lipid metabolism, 385
oxidative stress, 384
mycotoxins, 382
outbreak, 382, 383
pre-harvest approaches, 385
strategies to control, 385–386
Agricultural land, 266
Agriculture policies, 292
Agrochemicals
fertilizers, 266
pesticides, 266
Alpha linolenic acid (ALA), 398
Amaranth oil, 495
Amid chemical treatments, 195
Ammonia, 345
Anderson’s disease, 50
Animal starch, 49
Anterior pituitary gland
ACTH, 9
FSH, 9
growth hormones, 7
prolactin, 8
TSH, 8
Index
